Study of NGX267 Oral Capsules in Patients With Xerostomia Associated With Sjorgren's Syndrome

NCT00637793 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Xerostomia
Sjogren's Syndrome

Interventions

DRUG: NGX267
DRUG: NGX267
DRUG: NGX267
DRUG: NGX267

Sponsor

TorreyPines Therapeutics